Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA)
CUSIP: G9TY5A101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 108,236,654
- Total 13F shares
- 37,204,097
- Share change
- +3,192,322
- Total reported value
- $151,039,161
- Put/Call ratio
- 92%
- Price per share
- $4.06
- Number of holders
- 77
- Value change
- +$13,196,426
- Number of buys
- 53
- Number of sells
- 12
Quarterly Holders Quick Answers
What is CUSIP G9TY5A101?
CUSIP G9TY5A101 identifies ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G9TY5A101:
Top shareholders of ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BARCLAYS PLC |
3/4/5
13F
|
10%+ Owner · Company |
0.01%
from 13F
|
2,340,240
|
$24,349,729 | — | 09 Jan 2023 | |
| VR Adviser, LLC |
13F
|
Company |
5.6%
|
6,023,166
|
$21,081,081 | — | 30 Jun 2024 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
4.5%
|
4,860,939
|
$17,013,287 | — | 30 Jun 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
4.3%
|
4,642,241
|
$16,247,844 | — | 30 Jun 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
3%
|
3,283,783
|
$11,493,241 | — | 30 Jun 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3%
|
3,217,503
|
$11,261,261 | — | 30 Jun 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.3%
|
2,524,000
|
$8,834,000 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.2%
|
2,413,127
|
$8,445,945 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
1,201,079
|
$4,203,778 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.59%
|
633,663
|
$2,217,821 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.57%
|
612,389
|
$2,143,361 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.49%
|
535,080
|
$1,873,123 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.48%
|
515,899
|
$1,805,647 | — | 30 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
328,504
|
$1,149,764 | — | 30 Jun 2024 | |
| Michael Howell |
3/4/5
|
Chief Scientific Officer and Head of Translational Science |
—
mixed-class rows
|
529,904
mixed-class rows
|
$1,063,813 | — | 18 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.25%
|
267,759
|
$937,157 | — | 30 Jun 2024 | |
| Polar Asset Management Partners Inc. |
13F
|
Company |
0.24%
|
259,241
|
$907,344 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.21%
|
223,335
|
$781,673 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
192,835
|
$674,923 | — | 30 Jun 2024 | |
| Christopher Cabell |
3/4/5
|
CMO & Head of R&D |
—
class O/S missing
|
162,060
|
$648,240 | — | 18 May 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
172,853
|
$604,986 | — | 30 Jun 2024 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.14%
|
156,626
|
$548,191 | — | 30 Jun 2024 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.14%
|
155,490
|
$544,215 | — | 30 Jun 2024 | |
| Atom Investors LP |
13F
|
Company |
0.07%
|
77,416
|
$270,956 | — | 30 Jun 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.07%
|
73,396
|
$256,886 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.05%
|
51,737
|
$181,080 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
47,109
|
$164,882 | — | 30 Jun 2024 | |
| Forefront Analytics, LLC |
13F
|
Company |
0.04%
|
41,569
|
$145,497 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
35,445
|
$124,060 | — | 30 Jun 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.04%
|
38,999
|
$121,709 | — | 30 Jun 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
28,840
|
$100,940 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
24,804
|
$86,815 | — | 30 Jun 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.02%
|
23,657
|
$82,800 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
17,400
|
$60,900 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
16,894
|
$59,127 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
16,658
|
$58,303 | — | 30 Jun 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
12,319
|
$43,117 | — | 30 Jun 2024 | |
| Eisler Capital (US) LLC |
13F
|
Company |
0.09%
|
100,000
|
$40,000 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
11,413
|
$39,946 | — | 30 Jun 2024 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
11,279
|
$39,477 | — | 30 Jun 2024 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.01%
|
10,768
|
$37,688 | — | 30 Jun 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
8,547
|
$29,915 | — | 30 Jun 2024 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.01%
|
8,135
|
$28,473 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
7,221
|
$25,274 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
6,409
|
$22,432 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
6,149
|
$21,522 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
4,357
|
$15,250 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
2,308
|
$8,078 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,882
|
$7,000 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,906
|
$6,672 | — | 30 Jun 2024 |
Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) as of Q3 2024
As of 30 Sep 2024,
Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,204,097 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, ADAR1 Capital Management, LLC, Deep Track Capital, LP, GREAT POINT PARTNERS LLC, RA CAPITAL MANAGEMENT, L.P., BRAIDWELL LP, Point72 Asset Management, L.P., BlackRock, Inc., VR Adviser, LLC, and ARMISTICE CAPITAL, LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
55
Q3 2024 holders
77
Holder diff
22
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.